A study for efficacy of thalidomide in non-transfusion dependent thalassemia patients
Not Applicable
- Conditions
- Health Condition 1: D561- Beta thalassemia
- Registration Number
- CTRI/2024/05/068148
- Lead Sponsor
- Thalassemic charitable trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All patients with non-transfusion dependent thalassemia on hydroxyurea for at least 12 months.
Exclusion Criteria
1. Lack of consent
2. systemic illness- renal, hepatic or neurological.
3. HIV, HBV, HCV infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method